...
首页> 外文期刊>Journal of drug delivery science and technology >Preparation and characterization of pyrimethamine solid dispersions and an evaluation of the physical nature of pyrimethamine in solid dispersions
【24h】

Preparation and characterization of pyrimethamine solid dispersions and an evaluation of the physical nature of pyrimethamine in solid dispersions

机译:吡米甲胺固体分散体的制备与表征及嘧啶嘧啶物理性质的评价

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this investigation was to prepare, characterize pyrimethamine solid dispersions formulated with different carriers and to evaluate the physical nature of pyrimethamine in solid dispersion. Pyrimethamine solid dispersions were prepared by solvent evaporation technique using a rotary evaporator and characterized using intrinsic dissolution studies, differential scanning calorimetry (DSC), x-ray diffractometry (XRD), fourier transform infrared spectroscopy (FTIR), dissolution studies, and stability studies of selected solid dispersion. To further investigate the nature of drug, nuclear magnetic resonance was also performed. Intrinsic dissolution studies demonstrate that the dissolution rate of pyrimethamine could be markedly improved via solid dispersion technique. DSC studies show that PEG 6000 and poloxamer 188 could dissolve pyrimethamine up to 50% (w/w) in molten state. Results of XRD and FTIR suggest the presence of a different polymorphic form of pyrimethamine which might be due to the disruption of the supramolecular ribbon (synthon) formation of the original pyrimethamine polymorph. Significant improvement in dissolution rate from pyrimethamine solid dispersion using poloxamer 188 was achieved and pyrimethamine/poloxamer 188 ratio at 1:3 showing maximum dissolution rate enhancement of pyrimethamine. Furthermore, stability studies indicate no significant change in the physical nature of pyrimethamine in selected solid dispersion up to 5-month.
机译:该研究的目的是制备,表征用不同载体配制的吡米甲胺固体分散体,并评估酰甲胺在固体分散体中的物理性质。通过使用旋转蒸发器的溶剂蒸发技术制备吡米甲胺固体分散体,并使用内在溶解研究,差示扫描量热法(DSC),X射线衍射法(XRD),傅里叶变换红外光谱(FTIR),溶解研究和稳定性研究选择的固体分散体。为了进一步研究药物的性质,还进行了核磁共振。内在溶解研究表明,通过固体分散技术可以显着改善吡米甲胺的溶出速率。 DSC研究表明,PEG 6000和泊洛沙姆188可以将巯基甲胺溶解在熔融状态下高达50%(w / w)。 XRD和FTIR的结果表明存在不同多态性的嘧啶胺,这可能是由于原始吡酰胺多晶型物的超分子带(合成)的破坏。通过使用泊洛沙姆188的吡米甲胺固体分散体的溶出速率的显着改善,并在1:3的吡米甲胺/泊洛沙姆188比率显示吡米甲胺的最大溶解速率增加。此外,稳定性研究表明,在选择的固体分散体中没有显着变化,其在选定的固体分散中长达5个月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号